Download PDF
kleintier konkret 2014; 17(4): 11-17
DOI: 10.1055/s-0034-1384412
hund|katze
allergologie
Enke Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart

Calcineurin-Hemmer – Welche Anwendungsmöglichkeiten gibt es in der Dermatologie?

Petra J. Roosje
Universität Bern Vetsuisse-Fakultät, Departement für klinische Veterinärmedizin, Abteilung klinische Dermatologie
› Author Affiliations
Further Information

Publication History

Publication Date:
04 September 2014 (online)

Also available at
    Permissions and Reprints All articles of this category

Der orale Calcineurin-Hemmer Ciclosporin wird erfolgreich als Monotherapie oder in Kombination mit anderen Medikamenten in der Therapie von verschiedenen immunmediierten Hauterkrankungen bei Hunden und Katzen eingesetzt. Vor allem beim Hund können topische Calcineurin-Hemmer orale Therapien ergänzen oder ersetzen.

 

  • Literatur

  • 1 Forsythe P, Paterson S. Ciclosporin 10 years on: indications and efficacy. Vet Rec 2014; 174 Suppl 2: 13-21
    Google Scholar
  • 2 Gray LL, Hillier A, Cole LK et al. The effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogs. Vet Dermatol 2013; 24 (1): 118-125
    CrossrefGoogle Scholar
  • 3 Lortz J, Favrot C, Mecklenburg L et al. A multicentre placebo-controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment. Vet Dermatol 2010; 21 (6): 593-601
    CrossrefGoogle Scholar
  • 4 Marsella R, Nicklin CF, Saglio S et al. Investigation on the clinical efficacy and safety of 0,1 % tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Vet Dermatol 2004; 15 (5): 294-303
    CrossrefGoogle Scholar
  • 5 Misseghers BS, Binnington AG, Mathews KA. Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs. Can Vet J 2000; 41 (8): 623-627
    Google Scholar
  • 6 Olivry T, DeBoer DJ, Favrot C et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet Dermatol 2010; 21 (3): 233-248
    CrossrefGoogle Scholar
  • 7 Puigdemont A, Brazís P, Ordeix L et al. Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs. Vet J 2013; 197 (2): 280-285
    CrossrefGoogle Scholar
  • 8 Radowicz SN, Power HT. Long-term use of cyclosporine in the treatment of canine atopic dermatitis. Vet Dermatol 2005; 16 (2): 81-86
    CrossrefGoogle Scholar
  • 9 Stanley BJ, Hauptman JG. Long-term prospective evaluation of topically applied 0,1 % tacrolimus ointment for treatment of perianal sinuses in dogs. J Am Vet Med Assoc 2009; 235 (4): 397-404
    CrossrefGoogle Scholar
  • 10 Steffan J, Favrot C, Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Vet Dermatol 2006; 17 (1): 3-16
    CrossrefGoogle Scholar
  • 11 Steffan J, Parks C, Seewald W et al. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. J Am Vet Med Assoc 2005; 226 (11): 1855-1863
    CrossrefGoogle Scholar
  • 12 Steffan J, Horn J, Gruet P et al. Remission of the clinical signs of atopic dermatitis in dogs after cessation of treatment with cyclosporin A or methylprednisolone. Vet Rec 2004; 154 (22): 681-684
    CrossrefGoogle Scholar
  • 13 Wisselink MA, Willemse T. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomized prednisolone-controlled study. Vet J 2009; 180 (1): 55-59
    CrossrefGoogle Scholar